Key Points- Several women who have reported improvements in symptoms of polycystic ovary syndrome, a common hormonal disorder, after using GLP-1s such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.- Patients and some health experts view GLP-1s as a promising potential option for a condition that lacks a standard treatment and affects millions of women […]
